1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chronic Kidney Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Chronic Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alevizopoulou, F; Demopoulos, CA; Iatrou, C; Tsoupras, AB; Verouti, SN	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Chronic Kidney Diseases

Article	Year
Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. The International journal of artificial organs, 2013, Volume: 36, Issue:2 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Platelets; Cytokines; Diacylglycerol Cholinephosphotransferase; Dose-Response Relationship, Drug; Ergocalciferols; Humans; Inflammation Mediators; Leukocytes; Pilot Projects; Platelet Activating Factor; Platelet Aggregation; Rabbits; Renal Dialysis; Renal Insufficiency, Chronic; Thrombin; Time Factors	2013

Article

Year

Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.

The International journal of artificial organs, 2013, Volume: 36, Issue:2

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Platelets; Cytokines; Diacylglycerol Cholinephosphotransferase; Dose-Response Relationship, Drug; Ergocalciferols; Humans; Inflammation Mediators; Leukocytes; Pilot Projects; Platelet Activating Factor; Platelet Aggregation; Rabbits; Renal Dialysis; Renal Insufficiency, Chronic; Thrombin; Time Factors

2013